Moreover, we will examine the enhanced the cell death by combined treatment with perifosine and trametinib or PD0325901 in other human colorectal cancer cell lines harboring KRAS, BRAF and PIK3CA mutation. This evidence concerns the gene PIK3CA and colorectal cancer.